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Abstract 
Background: Five to 20 percent of the women worldwide suffer from Post Partum depression 
(PPD) which has serious negative impacts on the mother and her newborn. Although PPD is a 
preventive disease thorough screening using different tools, half of its cases are left undetected. 
Purpose of the study: Is to find the best practice for PPD screening, which includes the 
best screening tool, best setting for screening, best administration period and the best cut-off 
score. 
Methods: It is an Evidence-based Public Health (EBPH) review through a comparative 
study of 82 studies since 2005 that screened women for PPD in the postnatal period. All the 
articles were extracted from Pub Med, and each one used a definite screening tool for PPD. 
Results: Fifteen research articles reported on 82 studies that met study inclusion criteria. 
Six different screening tools were used in these studies. The most commonly used screening tool 
was EDPS (46 of 82 studies). Postpartum Depression Screening was conducted most often in in 
perinatal clinics (44 studies). Screening was most often administered around six weeks after 
delivery (57 of 82 studies). No consistent preferred cut-off score for positive PPD findings could 
be identified for the SPDS because the sensitivity and specificity was not consistent across the 
studies. 
Conclusion: The best practice for PPD screening is to use EPDS as screening tool for 
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Introduction
With all the excitement that accompanies the impending arrival of a new baby and with 
all the expected happiness the mother will have, there is unfortunately, an increase risk of
depression among new mothers. It is possible that the new mother may be affected by Post 
Partum Depression (PPD). PPD affects 5%-20% of the women worldwide during the postpartum 
period (Miller, 2002).
PPD is a major depression that occurs within the first 4 weeks after delivery and lasts for 
at least two consecutive weeks. The strongest predictor factor for PPD is antenatal depression 
(Leigh & Milgrom, 2008). Other risk factors are a previous depressive illness, life stress, lack of 
social support, psychological factors, marital dissatisfaction, obstetric factors, and low 
socioeconomic status (Robertson, Grace, Wallington, & Stewart, 2004).
PPD is different than normal depression because of the potential impact on the infant, the 
family as well as the mother. Untreated maternal depression is associated with disruptions in the 
infant’s cognitive (poor infant mental and motor development), emotional, and behavioral 
development. The infant may develop eating and sleeping problems, separation difficulties and 
temper tantrums (Csatordai et al., 2007). 
Early detection of PPD can’t be achieved in a routine antenatal exam. A special 
assessment that can detect high risk women is required. Primary prevention of PPD by early 
detection of high risk women and treatment is effective in reducing the undesirable outcomes 
that impact infants and result in restoring the mother to a healthy condition (Oppo et al., 2009). 
Purpose Statement 
The purpose of this study is to find the optimal evidence-based public health practices for 
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Literature Review 
Postpartum Depression 
The postpartum period is important for the new mother, her newborn and her family. 
Everyone expects this to be a time of joy and happiness for the family. With the new arrival it is 
usually so, but it is also a time when the mother faces new challenges of being a mother. She 
tries to meet the needs of her newborn, to adapt to the changes in her sleep pattern (most often 
the lack of sleep), and to physically recover from the delivery. All these factors put the new 
mother at risk for psychological distress during the postpartum period. Glavin, Smith, Sørum,
and Ellefsen (2010) mentioned three types of postpartum physiological problems: postpartum
blues, postpartum depression, and postpartum psychosis. Postpartum blues is the less severe 
problem and affects 50 to 80% of mothers. It starts one to five days after delivery and is 
manifested by fatigue, crying and emotional sensitivity. The most severe problem is postpartum
psychosis which affects 0.1% to 0.2% of new mothers during the first week following delivery. 
These women usually have delusional thoughts, hallucinations and severe emotional distress 
(Engqvist, Ahlin, Ferszt, & Nilsson, 2010). Between postpartum blues and postpartum psychosis 
there is postpartum depression (PPD). The prevalence rate of PPD is 7% to15%. The causes and 
risk factors for PPD are the same as for the depression outside the postpartum period. Risk 
factors include history of depression, stress, lack of social support and low socioeconomic status. 
PPD affects the health of the mother and her newborn, as well as her relationship within the 
family (Goodman, 2004). Usually the woman suffers from insomnia, fatigue, and low self-
esteem. The mother may suffer an inability to take care of her new baby either emotionally or 
physically which affects the infant’s attachment to his mother and may lead to cognitive and 
emotional problems during childhood. The high prevalence of PPD plus its wide range of effects 
makes PPD as a public health issue, but the good news about this disease is that it can be 
identified by screenings for the condition and treated before it reaches advanced stages. There 
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are many instruments and questionnaires that have been proven to be good screening tools. The 
Edinburgh Postnatal Depression Scale is the most widely used depression screening instrument 
(Hewitt et al., 2010). 
Postpartum depression definition and symptoms
Depending on the definition used the prevalence of PPD ranges between 0.5 – 60.8 
percent worldwide. PPD as defined by DSM-IV is a major depressive disorder that starts within 
the first four weeks after delivery (DSM IVTR; APA, 2000), while it is defined by ICD-10 
(International Statistical Classification of Diseases and Related Health Problems) (WHO, 2007) 
as a mild mental and behavioral disorder that begins within 6 weeks of delivery. 
The clinical manifestations of PPD include depressed mood, insomnia or hyper insomnia, 
feelings of worthlessness , loss of energy, markedly diminished pleasure in almost all activities, 
significant change in weight (weight loss or gain), psychomotor agitation or retardation, 
excessive guilt, reduced self-esteem and self-confidence, difficulty in concentration, and suicidal 
ideation (APA, 2000; WHO, 2007). The severity of depression after giving birth varies among 
women; it can be anything from postnatal blues (short and frequent symptoms of depression) 
(Edhborg, 2008), to severe psychosis with suicidal thoughts (Noble, 2005; Paulson, Dauber, & 
Leiferman, 2006). 
Etiology of postpartum depression 
Women are twice more likely to have major depressive disorder than men (Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005) and men usually do not suffer from PPD (Munk-Olsen, 
Laursen, Pedersen, Mors, & Mortensen, 2006) suggest that genetic factors and the female 
physiology system may be related to PPD. It is well documented that there are hormonal changes 
after delivery due to the rapid fall in estrogen and progesterone level and that these changes can 
lead to depressive mood (Paulson et al., 2006). While (Gleicher, 2007) pointed out to the 
possibility that PPD is an autoimmune disease depending on the new theory which says that 
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autoimmune disease is a result of the passage of fetal-maternal microorganisms (Gleicher, 2007) 
in the two directions. But Ross, Murray, and Steiner (2005) found that sleep disturbance and the 
change in the quality and quantity of the sleep after giving birth may be a cause of PPD not a 
consequence of it, his theory was first introduced by (Karacan, Williams, Hursch, McCauley, & 
Heine, 1969) and after that was supported with many studies (Frank, Kupfer, Jacob, Blumenthal, 
& Jarrett, 1987; Coble et al., 1994; Lee, McEnany, & Zaffke, 2000).
Impact of postpartum depression 
PPD is unique in the fact that it can affect the mother, her baby and as well as the whole 
family. Having a new baby should be a pleasant time for the mother and her family; this is not 
always the case. The mother may suffer from depression which could affect her connection with 
the new baby and could decrease her ability of taking care of the baby. This has the potential to 
result in feelings of guilt and hopelessness. Having PPD can increase the mother’s susceptibility 
to smoke and to abuse alcohol and drugs. The risk for physical, emotional and sexual abuse is 
also elevated because the women are more vulnerable to different types of abuse during this 
period. Fairbrother and Woody (2008) found also that women with PPD may be more likely to 
have intense thoughts of either accidentally or intentionally hurting the baby. PPD may have 
long-term influences on the mother-infant relationship and on child development; this effect is 
gender- specific as male infants are more affected by maternal depression than female infants. 
When the interaction between the mother and her infants is affected by PPD the result can be 
lower cognitive functioning and emotional problems (Tronick & Reck, 2009).  
Untreated maternal depression affects the mother’s ability to take care of her new baby. 
She is less likely to respond to the baby’s cues. The mother’s parental behaviors are affected by 
depression with things such as feeding the baby, sleep patterns, breast feeding and paying 
attention to safety habits. The mother’s depression, if left untreated, may result in her children 
 
7 EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD 
suffering from psychiatric problems such as anxiety and affective disorders during their 
childhood (Csatordai et al., 2007). 
Risk factors for postpartum depression  
Risk factors for PPD fall into different categories: strong, strong-moderate, moderate, and 
mild. Experiences of depression or anxiety during pregnancy or a previous depressive illness are 
the strongest risk factors (Robertson et al., 2004). Early detection and treatment of depression 
during pregnancy is very critical, as untreated cases can develop to postpartum depression with 
its negative outcomes on the mother and her baby (Ryan, Milis, & Misri, 2005). 
Johanson, Chapman, Murray, Johnson, and Cox (2000) reported that one third of PPD 
cases progress though a continuum of depression during pregnancy. Josefsson, Berg, Nordin, and 
Sydsjo (2001) followed 417 women during pregnancy until 6 weeks after birth that the rate of 
depression decreased from 17% during late pregnancy to 13% at week 4-6 after delivery. 
Life stress and lack of social support have a moderate to severe influence on PPD 
(Robertson et al., 2004). Robertson, Grace, Wallington, and Stewart (2004) said that women who 
experience two or more stressful life events the year before pregnancy are more likely 
predisposed to PPD. Stressor events are life experience such as death of a family member, loss of 
one’s job, moving, and a chronic disease diagnosis. Social support is usually having people 
available who can offer help to the mother taking care of her new baby and who can support her 
emotionally during the pregnancy and at postpartum period (Pope, Watts, Evans, McDonald, & 
Henderson, 2000); while lack of social support has negative impact on the mother and increases 
her risk for PPD (Honey, Morgan, & Bennett, 2003). 
Psychological factors have a moderate effect (Robertson et al., 2004). Mothers with low 
self esteem (Ritter, Hobfoll, Lavin, Cameron, & Hulsizer, 2000), those who are perfectionist and 
those who have high interpersonal sensitivity are more likely to develop PPD (Boyce, Parker, 
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on PPD (Robertson et al., 2004). A history of miscarriages or terminations of pregnancies can 
increase the mother’s risk for PPD (Pope et al., 2000; Robertson et al., 2004). Low 
socioeconomic status and low educational attainment also have small impacts on PPD (Patel, 
Rodrigues, & DeSouza, 2002; Tammentie, Tarkka, Astedt-Kurki, & Paavilainen, 2002). 
Depression during pregnancy and family history of depression: Depression during 
pregnancy results in negative consequences for both the baby and the mother. Depression during 
pregnancy is associated with a three to fourfold increase in PPD within six month after delivery 
(Oppo et al., 2009). It can lead to preterm birth, increasing in smoking behavior, deteriorating of 
social function and emotional withdrawal which are themselves predisposing factors for PPD 
(Bowen & Muhajarine, 2006). Robertson and colleagues (2004) found that depression during 
pregnancy is a strong predictor of postpartum depression. This supports the hypothesis that 
postpartum depression is a continuation of major depression that occurred during pregnancy. 
Kumar and Robson (1984) reported that other studies found that major depressive symptoms can 
occur prenatal and not reoccur in the postnatal period or can start in the postpartum period 
without having experienced depression during pregnancy. These studies suggest that antenatal 
and postpartum depressions are distinct disorders. While it is well confirmed that major 
depression disorder is familial, it cannot be confirmed that genetic factors predispose women to 
PPD (Murphy-Eberenz et al., 2006). 
Postpartum depression and anxiety: Anxiety is considered a normal consequence of the 
physiological and psychological changes during pregnancy especially if the anxiety is related 
toward the health of the baby and the concerns about being a mother, such as the new tasks 
associated with taking care of the baby and at the same time maintaining the perfect image as a 
mother of other children if she has other children. These concerns may also extend to her role as 
a wife. A history of anxiety during the first trimester is not a predictor for PPD. However, in 
some cases anxiety can be related to panic disorder which is a strong predictor of PPD. A history 
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of panic disorder during the first trimester of pregnancy increases the chance of PPD by 4.2 
times. If the mother has a family history of panic disorder the risk for PPD is 2.1 times as high. 
Rambelli and colleagues (2010) said that panic disorder should be identified and treated as a 
measure to prevent the development of PPD. Anxiety during pregnancy is twice as common as 
depression, but depression in the postpartum period is twice as common as anxiety (Heron, 
O’Connor, Evans, Golding, & Glover, 2004). While studies found that a history of anxiety 
during the first trimester is not a predictive factor for PPD, Sutter-Dallay, Giaconne-Marcesche, 
Glatigny-Dallay, and Verdoux (2004) found at their MATQUID cohort study that women with a 
history of anxiety disorder during third trimester are three times more likely to experience PPD.  
Postpartum depression and smoking: Both smoking and PPD are maternal and treatable 
conditions that have adverse effects on the mother and her newborn. Smoking is associated with 
increasing the infant’s risk for sudden infant death, low birth weight, attention­
deficit/hyperactivity disorder, asthma, and otitis media (National Cancer Institute, 1999, 
Milberger, Biederman, Faraone, Chen, & Jones, 1996). Many researches had been found that 
smoking is associated with increased incidence of postpartum depression (Bryan, Georgiopoulos, 
& Harms, 1999). A study that surveyed 4,353 women 15 months after delivery found that the 
prevalence of a major depressive episode is higher among smokers (17.7%) than nonsmokers 
(12.1%), smoking was also more common among mothers who have experienced a major 
depressive episode than in those without one: 34.0% vs. 25.5%, so when these two conditions 
co-occur they have to be treated at the same time (Whitaker, Orzol, & Kahn, 2007).  Research 
studies had found that smoking can cause preterm delivery and low- birth weight infants which 
in turn can increase the risk of PPD support, lack of education, low income and smoking which 
are also risk factors for PPD (Gungor, Oskay, & Beji, 2011). 
Postpartum depression and social support: Social support is defined as the interpersonal 
resources that are accessed and mobilized when individuals attempt to deal with the everyday 
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stresses and strains of life (Chen, Tseng, Wang, & Lee, 1994). The research studies found that 
Lack of social support is associated with increased risk of PPD. Several studies pointed out that 
social support can reduce bad behaviors among women at the postpartum period as smoking and 
drug abuse (Brugha et al., 1998; Collins, Dunkel-Schetter, Lobel, & Scrimshaw, 1993). Support 
is usually provided by the husband or partner through emotional support, a family member by 
taking care of the baby or hospital personnel by giving advice regarding nursing the baby and 
taking care of his hygiene. 
Cultural activities during pregnancy vary between populations. Cultural practices could 
help in decreasing the chance of PPD or they could increase it. Many cultures have different 
ideas about how to deal with the confinement period following the birth. Some societies consider 
this time as an individual and private time and they leave the new mother alone to deal with the 
new baby as is the custom in western culture. In eastern culture there is a wide interference with 
the new mother and her newborn daily life; usually mother or mother-in-law determines the food 
the mother will eat, the time of the mother’s bath, and the way she and her baby dress (Wan et 
al., 2008). 
In eastern culture the families of the new parents play an important role during the 
confinement period which is usually lasts up to 40 days after delivery. The new mother usually is 
able to rest physically during this time. There is someone who is taking care of the mother’s 
needs, the baby’s needs, and the housework. It is also a time when a lot of people come to 
congratulate the new mother, but at the same time the trade-off is that they interfere with every 
single detail in her behavior regarding taking care of herself and her baby. How the mother 
tolerates the ritual confinement period may improve interpersonal relationships and enhance the 
health of the women, or it may be perceived as violations of privacy and the mother’s time with 
the baby (Klainin & Gordon, 2009). 
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In some cultures, as in Turkey, giving birth is a protective factor against depression 
because the level of social support the mother usually receives at this period which include the 
physical and emotional respect; women in Turkey usually stay resting after birth while many of 
her family members take care of the home chores and the newborn needs, they also throw parties 
to appreciate her and to welcome the baby (Kara, Unalan, Cifcili, Cebeci, & Sarper, 2009). In 
China the social support the new mother gets during the first month after delivery, which is 
usually called Zuoyuezi, could double the risk of PPD if it is provided by the mother in law. The 
mother-in-law has a lot of power over her daughter-in-law. Often she uses this power to control 
the life of her daughter-in-law in the postpartum period and to impose more pressure on the new 
mother. This pressure can increase the chances the mother will experience depression (Wan et 
al., 2009). 
Postpartum depression and violence: Violence during pregnancy affects the physical and 
mental health of the mother and it also affects the health of the baby (Romito, Pomicino, 
Lucchetta, Scrimin, & Turan, 2009). Cohen, Schei, Ansara, Gallop, and Stewart (2002) found 
that only emotional abuse plays a role in elevated the risk of PPD, sexual or physical abuse do 
not increase the risk of PPD. Violence during the postpartum period is more common than during 
pregnancy. The rate of violence during pregnancy varies worldwide between 6% and 17%. The 
risk factors for partner violence are almost the same as the risk factors for post-partum
depression. These include: financial dissatisfaction, migration status, unwanted pregnancy and 
being unemployed (Saurel-Cubizolles & Lelong, 2005; Saltzman, Johnson, Colley, & Goodwin, 
2003). 
Postpartum depression and socioeconomic status: Many studies around the world had 
been conducted to find the impact of income, educational level and employment status on the 
occurrence of PPD. The influence of low income increasing the chances of PPD was confirmed 
in some studies in the USA (Segre, O'Hara, Arndt, & Stuart, 2007), Brazil (Tannous, Gigante, 
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Fuchs, & Busnello, 2008), and Turkey (Gulseren et al., 2006). In other studies in the USA 
(Goyal, Gay, & Lee, 2010) and Japan (Miyake, Tanaka, Sasaki, & Hirota, 2011) found that low 
income does not increase the chance of PPD. There are also different results for the association 
between employment status and the incidence of PPD; some studies found that full employment 
job reduces the occurrence of PPD (Mayberry, Horowitz, & Declercq, 2007). Others confirmed 
that employment status does not have any role in increasing the possibility of PPD (Goyal et al., 
2010). While Patel, Rodrigues, and DeSouza (2002) reported that in India full time employment 
increases the risk for PPD. Although there was no agreement among the research studies 
regarding the impact of income and employment status on the occurrence of PPD, there was an 
agreement regarding the effect of educational level; they found that educational level does not 
increase or decrease the risk of PPD (Goyal et al., 2010; Miyake et al., 2011). But one interesting 
result comes from the result of the prospective study in Japan (Miyake et al., 2011) which 
claimed that holding a high prestigious job (which is associated with a high level of education) is 
a protective factor against PPD. 
Postpartum depression and parity: Although research studies found an association 
between multiparty and depression during the third month of pregnancy (Borri et al., 2008), no 
difference in the rates of PPD were found between multiparous and primiparous women. 
Multiparous women had more risk factors for PPD such as lack of social support, previous 
depression, marital dissatisfaction and low self esteem than primiparous women. But multiparous 
women receive more psychological and drug treatment for depression (Oppo et al., 2009). 
Postpartum depression and lack of sleep: Sleep disturbance is very common during the 
post-partum period because of the newborn pattern of feeding and sleep. Although there is an 
association between lack of sleep and PPD, the relationship is not fully documented, because of 
the ambiguity of the definitions of the terms (Hunter, Rychnovsky, & Yount, 2009). 
13 EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD 
Postpartum depression and infant health: Delivery before 37 weeks of pregnancy is 
called preterm birth. It has been proven that pre-term infant is associated with higher risk for 
PPD. At the same time it is well known that pre-term is associated with low social support, lack 
of education, low income and smoking which are also risk factors for PPD (Gungor, Oskay, & 
Beji, 2011). 
Treatment for Postpartum Depression 
Usually there is a delay for the treatment for PPD because mothers do not like to admit 
they have psychological symptoms due to the social shame of a possible psychiatric illness. 
Mothers also do not realize that they are sick but their symptoms instead contribute their feeling 
of failure as a mother. 
Treatment of PPD is similar to the treatment of depression outside the postpartum period, 
except for additional concerns during  this period;  concerns of breastfeeding, hormonal changes 




No difference in the mother’s response for antidepressant medication was found during 
postpartum period and outside of this period (Payne, 2007; Pearlstein, Howard, Salisbury, & 
Zlotnick, 2009). Many open- label studies have been conducted and shown the effectiveness of 
many types of antidepressants for PPD; venlafaxine (Cohen et al., 2001), sertraline (Stowe & 
Nemeroff, 1995), bupropion (Nonacs et al., 2005), fluvoxamine (Suri, Burt, Altshuler, 
Zuckerbrow-Miller, & Fairbanks, 2001) and paroxetine (Misri, Reebye, Corral, & Milis, 2004).  
Antidepressants and breast feeding 
The importance of breastfeeding for the health of the mother and the baby is well known. 
As a result the American Academy of Pediatrics recommends that mothers have to breastfeed 
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their babies. However a big concern is when we will treat a breastfeeding mother with any 
medication in general and with antidepressants in particular due to scarce data regarding safety. 
Eberhard-Gran, Eskild, and Opjordsmoen (2006) found a low number of reported adverse effects 
when using tricycles and SSRIs during breastfeeding. Many considerations have to be taken as a 
safety procedures while taking antidepressants, for instance, taking the medicine after 
breastfeeding and before sleeping , using medication that was effective during previous episodes 
of depression, using the same medication that was used during pregnancy because the infant had 
been already exposed to that medication; and finally, the family member has to be familiar with 
the side effects of the medication on the infants such as sleep and agitation (Payne, 2007).  
Hormonal treatment 
Use of hormone treatment can be effective because the change in the estrogen and 
progesterone during the postpartum period can be responsible for the maternal mood changes 
(Moses-Kolko, Berga, Kalro, & Wisner, 2009). 
Non-pharmacological 
Some mothers find non-pharmacological treatments desirable if they breastfeed their 
infants. This includes psychological and psychosocial treatments; both these treatments were 
found to be effective in decreasing post-partum depression (Dennis & Hodnett, 2007).  
Psychological treatment includes Interpersonal Therapy (IPT) and Cognitive Behavioral 
Therapy (CBT) while psychosocial treatments include nondirective counseling and peer and 
partner support (Fitelson, Kim, Baker, & Leigh, 2011). 
Screening for post-partum depression
Screening for PPD is very useful in identifying women at risk for PPD. Women who are 
identified as high risk should be offered appropriate treatment and prevention strategies to reduce 
the chance of occurrence of PPD and the negative outcomes that will affect the mother and her 
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instruments are considered to be a good prevention tool to help identifying women with high risk 
factor for PPD during their pregnancy or in the postpartum period (Oppo et al., 2009). 
These instruments are: 
1. Beck Depression Inventory (BDI) 
2. Beck Depression Inventory (BDI-II) 
3. Bromley Postnatal Depression Scale (BPDS) 
4. Center for Epidemiologic Studies Depression Scale (CES-D) 
5. Clinical Interview Schedule (CIS)
6. Diagnostic Interview Schedule (DIS) 
7. Edinburgh Postnatal Depression Scale (EPDS) 
8. General Health Questionnaire (GHQ) 
9. Inventory of Depressive Symptomatology (IDS) 
10. Postpartum depression Screening Scale (PDSS) 
11. Zung Self-Rating Depression Scale (Zung SDS)
12. Pregnancy Health Questionnaire (PHQ) 
13. Pregnancy Health Questionnaire-9 (PHQ-9) 
14. Two question screen of the PHQ 

The most commonly used screening instruments for PPD are: 

Edinburgh Postnatal Depression Scale (EPDS)
EDPS is designed to assess post-partum depression. It was first designed for use by 
women who speak English. It has subsequently reached non-speaking English countries. It is a 
self-report instrument which has 10 items. Items written in the past tense include statements 
relating to feelings mothers experienced in the past seven days and evaluate depressed mood, 
anhedonia, guilt, anxiety and suicidal ideation. The EPDS is usually administered by the paper 
and pencil method although computerized versions are available; it is brief, taking approximately 
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5 minutes to complete, and easy to administer, score and interpret. It is a self-report instrument 
which has 10 items. The range of scores is from 0 to 30. A score above 12 suggests a high 
possibility the woman is experiencing PPD. EPDS has a high specificity and sensitivity 
(Adewuya, Eegunranti, & Lawal, 2005). It is necessary to consider that the cut-off score should 
be set at different levels for different countries (Nishimura & Ohashi, 2010). The EPDS is used 
to evaluate postpartum depression at birth and at six, 12, 18 and 24 weeks post-partum (Boyce & 
Hickey, 2005). 
Postnatal Depression Screening Scale (PDSS) 
The PDSS is a postpartum depression screening tool that can identify women who could 
suffer from PPD. It is a 35-item Likert-type response scale that can take 5 to 10 minutes to 
complete; it is brief and easy to understand and interpret. The PDSS consists of seven 
dimensions (each of them contains five items). The dimensions include sleeping and eating 
disturbances, anxiety/insecurity, emotional liability, cognitive impairment, loss of self, 
guilt/shame, and thoughts of self-harm. Each item describes the type of feelings a woman may 
experience after the birth of a child. Mothers are asked to indicate their feelings on a 5-point 
scale ranging from ‘strongly agree’ to ‘strongly disagree’ regarding how they have felt in the last 
2 weeks. Scores of 80 or above indicate major depressive disorder while 60 or above indicate 
minor depression disorder. It has a sensitivity of 91% to 94%, specificity of 72% to 98% and a 
positive predictive value of 33% to 88%.  
Beck Depressive Inventory (BDI) 
The BDI instrument contains 21 items related to particular symptoms of depression in the 
last week. Even though this is a general depression scale it has been used frequently with 
pregnant and postpartum women (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). Each item
is scored from zero to three in terms of intensity where (0) I do not feel sad, (1) I feel sad, (2) I 
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total score of the 21 items is interpreted as follows: 0 to 9 indicates minimal depression, 10 to 18 
indicate mild depression, 19 to 29 indicate moderate depression, 30 to 63 indicate severe 
depression, and higher scores indicate more severe depression (Beck et al., 1961).  
Beck Depressive Inventory-II (BDI-II)
In response to the change of many of the diagnostic criteria for Major Depressive 
Disorder by the American Psychiatric Association's publication of the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, A new version of BDI was created in 1996, this 
version is BDI-II. In this revision some items were replaced (changes in body image, 
hypochondria, and difficulty working), some were revised (sleep loss and appetite loss items), 
and some remained the same (items dealing with feelings of being punished, thoughts about 
suicide, and interest in sex). Also as opposed to ask about the feelings in the past week as in the 
original BDI, participants were asked to rate how they have been feeling for the past two weeks. 
BDI and BDI-II both contain 21 questions, each answer scores on a scale value of 0 to 3. 
The cut-off scores used in BDI-II differ from the original BDI: 0 to 13 indicates minimal 
depression; 14 to 19 indicate mild depression; 20 to 28 indicate moderate depression; 29 to 63: 
severe depression and higher total scores indicate more severe depressive symptoms. 
(General Health Questionnaire) GHQ 12 
GHQ (Goldberg, 1972) is a self-administered questionnaire that has 60 items; it is 
originally used to detect common mental disorder such as anxiety and depression among general 
medical patients. GHQ-12 is GHQ version that has 12 items of the 60 original items; it evaluates 
the response for each item using a four-level alternative response scale and the total score ranges
from zero to 12. Boyd, Le, and Somberg (2005) recommended the 12-item GHQ to detect 
postpartum depression because this version is the shortest type of GHQ and has a slightly higher 
sensitivity and positive predictive value. Among general population, GHQ 12 has76% sensitivity 
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Patient Health Questionnaire 9 (PHQ-9)
The PHQ-9 is a nine-item self-report depression screening tool that evaluates symptoms
experienced during the past 2 weeks (Kroenke, Spitzer, & Williams 2001). Each item includes 
four possible responses that correspond to the duration of the symptoms. There are two scoring 
methods for PHQ-9: summary scoring algorithm and a diagnostic algorithm. In the summary 
scoring (simple scoring), scores ≥10 of a scale range 0 to27 are often used to screen for major 
depression (Kroenke & Spitzer, 2002). The PHQ-9 diagnostic algorithm scoring (complex) is 
based on DSM-IV depression diagnostic criteria (Spitzer, Kroenke, & Williams, 1999). Patient
must have at least five depressive symptoms at least “more than half of the days” and at least one 
of those must be depressed mood or loss of interest.  
Research Questions
This study the best practices for PPD screening. These practices include the best 
screening tool depending on the most common used tool and the best sensitivity and specificity, 
the best time and setting for screening, and the best cut-off score. There are 13 screening tools 
for PPD used in various settings around the world; six of these are most commonly used. This 
study is designed to identify the screening instrument that is best identifying for depression 
among women during the postnatal period. 
Methods
According to Brownson, Fielding, and Maylahn (2009), one key component of Evidence-
based Public Health (EBPH) is to make decisions based on the best available scientific data. This 
study is an EBPH review in which an analysis of Post Partum Depression (PPD) using published 
literature is provided. Pub med, WSU library and Ohio LINK were searched for articles using the 
following search terms: antenatal depression, postnatal depression, postpartum depression, 
screening, prevention, and best practices. In addition, the references cited in the published 
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Criteria for the selection of studies: To be included in this analysis, a study had to meet 
all of the following criteria:
1.	 Women were screened for PPD using at least one of the 13 validated screening tools 
for PPD.
2.	 Women were screened during the postnatal period (from birth until 18 month after 
delivery). 
3.	 The diagnostic criteria of PPD for the study were based on the DSM-IV, DSM-III 
and International Classification of Diseases (ICD-10). The study was published in 
2005 or later. 
4.	  The study was written (or translated) in English. 
The requirement that studies be published in 2005 or later insured that findings are based 
on the most current research. The studies in this research were not restricted to a specific location 
or country; all international studies that met the criteria for inclusion were included. It was not 
necessary to exclude articles based on sample size; the minimum sample size in the studies was 
104. Studies reviewed for this research include all women in the child bearing ages (15 to 44). 
All settings in which screenings were conducted were included in this study. Screening 
can be done at a variety of locations, including primary care physician’s office, OB/GYN 
physicians’ office, pediatrician’s office, and health departments or even by phone, or in the 
patient’s home. Studies were reviewed to ensure that a rigorous protocol was used to screen 
mothers and confirm the mothers would be able to understand all the questions in the 
questionnaire. It was not necessary that the person who administered the screening instrument be 
physician or a psychiatrist, only that he or she had the ability to ask the questions clearly and to 
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Types of screening: Each study used at least one PPD screening instrument during the 
postnatal period to classify women as either at risk or not at risk of postnatal depression, on the 
basis of reliable diagnostic criteria.
Study measures: The following characteristics of the screening instrument were sought: 
1. 	 The title of screening instrument(s) used in each study was recorded. 
2. 	 Cut-off score: Most of the instruments used more than one cut-off score to 
determine which participants are at risk for PPD. 
3. 	 Sensitivity and specificity: Sensitivity of the screening instrument is an essential 
outcome measure examined in this analysis. Sensitivity and specificity rates for 
each cut-off score for an instrument were recorded for each article.  
4	 Time of the screening: the time within the postnatal period in which screening was 
conducted was recorded for each study. 
Calculated Measures
Sensitivity of the screening instrument is an essential outcome measure used to analyze 
the usefulness of screening tools in detecting whether women have PPD. Sensitivity is defined as 
the ratio between those patients who test positive and all those patients who actually have the 
disease, whether their tests are positive or false negative. Most studies reported the sensitivity of
each screening tool. If the sensitivity was not available it was calculated using this formula: 
Sensitivity = TP / (TP+FN), where TP is the number of true positives (the patient screened 
positive for PPD and received a PPD diagnosis). FN is the number of false negatives (the patient 
screened negative for PPD but received a PPD diagnosis).  
Specificity of the screening instrument is another essential outcome measure used to 
analyze the effectiveness of screening tools. Specificity is defined as the proportion of patients 
without the disease who test negative. Most of the studies reported the specificity for each 
screening tool and for each cut-off score used for that tool. If the specificity was not available it 
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was calculated using this formula: Specificity= TN / (TN + FP), where TN is the number of true 
negatives (patient screened negative for PPD and did not receive a diagnosis of PPD). FP is the 
number of false positives (patient screened positive for PPD but did not receive a diagnosis of 
PPD). 
Analytical criteria: 
The data abstracted from each paper were tabulated using Microsoft Excel. Results were 
collected by instrument and cut-off scores used to determine whether a woman was at risk of 
PPD, the rate of depression in each study was reported. For each cut-off score for each 
instrument the mean, median, the standard deviation, the range, the Number Needed for 
Diagnosis NND and the Youden score were calculated for the specificity and sensitivity. In 
addition, the mean, median and range of the maternal age and the rate of PPD were also 
calculated.
Number needed to diagnose (NND) is a function of sensitivity and specificity, which are 
tend to remain highly stable across populations. The NND indicates the number of tests that need 
to be undertaken in order to get a positive diagnosis, its formula is:  
NND=1/ [sensitivity-(1-specificity)]. It gives a comparison between tests. An optimal 
NND value would be close to 1.0 (Batstone, 1997). 
Youden index: It measures the effectiveness of a diagnostic marker and help in the 
selection of an optimal cutoff point. It is calculated as (sensitivity +specificity-1); it has 
minimum and maximum values of -1 and +1, with an optimal value +1 (Schisterman, Faraggi, 
Reiser, & Hu, 2008). 
A count was used to identify which screening tool was most commonly used. The 
sensitivity and specificity for each tool and for each cut-off score used were evaluated based on 
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Criteria for determination of evidence-based screening practices: 
The best screening tool for PPD: was detected depending on four criteria (chosen by the 
author of this study): 
1.	 The best setting in which to screen for post-partum depression was determined by 
reviewing the settings in which the instruments were used in each study. The most 
commonly used setting across all the studies was identified as the best setting in 
which to screen for post-partum depression. 
2.	 The best time-period in which to screen for post-partum depression was determined 
by reviewing the time-periods in which the instruments were used in each study. 
The most commonly used time-period across all the studies was identified as the 
best setting in which to screen for post-partum depression. 
3.	 The most commonly used instrument was determined by reviewing the number of 
times each instruments was used in peer reviewed research articles. The instrument 
with the largest number of uses in studies is the most commonly used instrument. 
The most frequently studied instrument was detected by the number of times each 
instrument was used in the various studies. Several of the research projects used one 
of the Post-Partum Depression Screening instruments more than once with different 
cut-off scores to determine which score was the most successful for determining 
whether a mother was at risk of PPD. The numbers of times each of the instruments 
were studied across all the articles were summed. The instrument with the largest 
number was considered most frequently studied instrument.  
4.	 The optimal cut-off score for the most commonly used screening tool: the sensitivity 
of the screening tool is very important from a clinical perspective. If the screening 
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(sensitivity). But at the same time it is important to not falsely identify post-partum
women as depressed when they are not (false positives). An increase in false 
positive results in a decrease in the specificity. The most sensitive cut-off score was 
identified by comparing the mean and the standard deviation of the sensitivities for 
the instrument. The goal is to identify the cut-off score with the highest mean 
sensitivity with the smallest standard deviation paired with the highest mean 
specificity with the smallest standard deviation. The optimal sensitivity and 
specificity is likely to not include the highest value for either measure. 
Results
A total of 82 studies (published in 16 articles), met the inclusion criteria. Each of the 
articles had at least one study depending on the number of screening tool and the number of 
different cut- off point that had been used. A full list of included studies can be found in the 
Appendix 1. 
Postpartum Depression Screening Instruments
1. Most commonly used instruments 
Six screening tools were evaluated in this research from the 16 articles reviewed. Some
articles used more than one screening tool in their research; these tools were Edinburgh Post­
natal Depression (EPDS), Beck Depression Inventory (BDI), Beck Depression Inventory II 
(BDI-II), Post-natal Depression Screening (PDSS), Pregnancy health Questionnaire (PHQ-9), 
and General Health Questionnaire (GHQ-12). 
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Table 1. Evaluated Screening Tools and Number of Studies  







EPDS was used 11 times across the 16 studies; it was studied 46 times in different studies 
compared to the next most commonly studied instruments, the PDSS (12 times) and BDI (8 
times). The EPDS was the most frequently used and most commonly studied screening tool. 
2. Setting 
Table 2 shows the setting in which the postpartum depression screening instruments were 
across the different studies. 
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Table 2. Setting for PPD Screening 




Hospital Maternity Clinic 
Jardi, 2006 France EPDS 7 16.1% 
Agoub, 2005  Morocco EPDS 4 6.9% 
Austin, 2005 Australia EPDS 1 5.2% 
Teng, 2005 Taiwan BDI-II 3 10.3% 
Post-Natal/Perinatal Clinic 
Navaro, 2007 Spain EPDS 8 25.4% 
Pitanupong, 2007 Thailand EPDS 7 1.0% 
Abiodun, 2006 Nigeria EPDS 7 18.6% 
Adewuya, 2005 Nigeria EPDS 6 14.6% 
Hanusa, 2006 USA EPDS 1 11.0% 
Navaro, 2007 Spain GHQ-12 7 25.4% 
Adewuya, 2005 Nigeria BDI 6 14.6% 
Hanusa, 2006 USA PDSS 1 11.0% 
Hanusa, 2006 USA PHQ-9 1 11.0% 
Outpatient – Primary Care 
Gjerdingen, 2009 USA PHQ-9 2 8.9% 
Flynn, 2011 USA PHQ-9 1 73.0% 
Flynn, 2011 USA EPDS 1 73.0% 
Chaudron, 2010 USA EPDS 1 37.0% 
Chaudron, 2010 USA PDSS 1 37.0% 
Chaudron, 2010 USA BDI 1 37.0% 
Community Based Organization 
Vittayanont, 2006 Thailand PDSS 6 1.0% 
Milgrom, 2005 Australia EDPS 3 8.0% 
Milgrom, 2005 Australia BDI 3 8.0% 
Acute care Clinic 
Beck, 2005 USA BDI 4 18.0% 
The setting of PPD screening had been done 44 times in post-natal/perinatal clinics, 15 
times in hospital maternity clinics, 12 times in community based organization, seven times in 
out-patient- primary care and four times in acute care clinics
Studies were undertaken in different countries:, 19 in Nigeria, 15 in Spain, 14 in USA, 13 
in Thailand, 7 in France, 7 in Australia, 4 in Morocco and 3 in Taiwan. The diversity of cultures 
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The EPDS was used in all of these countries except in Taiwan, where the local version 
was used. EPDS had been translated to the local spoken language at each country where English 
is not the spoken language. 
3. Administration period 
The administration period for PPD screening using EDPS was in a range from birth up to 
56 weeks postnatal, 33 of the studies contracted patients in a window of time around six weeks 
after delivery. Seven studies contacted patients between three to five days postpartum and one 
study extended their screening period up to 56 weeks postpartum.
The administration periods for other screening tools in our study were almost at the same
range of EPDS. Administration periods for the studies that used BDI, BDI-II, PDSS, PHQ, and 
GHQ-12 were in a range of two weeks and 56 weeks postnatal, where 24 studies contracted 
around six weeks, four studies had an administration period between two and 12 weeks and two 
studies had a long administration period from two weeks until 14 months, while three other 
studies occurred at four month postnatal. 
Table 3. Administration Period for PPD Screening 
Study, Country, Year 
PPD 
Rate Time of screening 
Austin, 2005, Australia 5.20% 32 weeks gestation, 2-4 month postnatal 
Jardi, 2006, France 16.10% 3 to 5 days postnatal 
Beck, 2005, USA 18.00% 2 to12 weeks postnatal 
Chaudron, 2010, USA 37.00%  2 weeks to 14 months postnatal 
Hanusa, 2006, USA 11.00% 6 to 8 weeks after birth 
Abiodun, 2006, Nigeria 18.60% 6 weeks postnatal 
Agoub, 2005, Morocco  6.90% 6 weeks, 6 and 9 months postnatal 
Navarro, 2007, Spain 25.40% 6 weeks postnatal 
Pitanupong, 2007,Thailand 1.00% 6 to 8 weeks after birth 
Vittayanont, 2006,Thailand 1.00% 6 to 8 weeks after birth 
Adewuya, 2005, Nigeria 14.60% 6 weeks postnatal 
Teng, 2005, Taiwan 10.30% 6 weeks postnatal 
Milgrom, 2005, Australia 8.00% 4 months postnatal 
Gjerdingen, 2009, USA 8.90% N/A 
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4. Cut-off scores and sensitivities and specificities
The recommended cut-off score for EPDS is 10, at this score women who are at increased 
risk for PPD can be detected and at the same score there are a reasonable number of false 
positive cases (Cox, Holden, & Sagovsky, 1987). To determine if a more optimal cut-off score 
could be identified researchers tested the EPDS instrument using a wide range of cut-off scores 
in efforts to determine the optimal cut-point to identify women at risk of postpartum depression. 
In 45 studies in populations across the world cut-off scores between six and 14 were used. In 
some cases decimal cut-off scores were used, these were rounded to the nearest whole number. 
Table 4 shows the number of studies conducted using these cut-off scores and the average 
sensitivity and specificity for studies that used a certain cut-off score. The sensitivity and 
specificity for EPDS varied depending on the cut-off score considered and the population 
studied. The table below is showing that the average of the sensitivity among different studies is 
the highest at the cut-off score 6 (0.91) and it is the lowest at the cut-off score 14 (0.40). The 
average of sensitivity decreased as the cut-off score increased. The exception was at the cut-off 
score 13 which had an average sensitivity of 0.71 following a sensitivity of 0.61 for the cut-off 
score of 12. The average specificity ranged from 0.61 to 1.00. The average of specificity was 
increasing as the cut-off score was increasing except at the cut- off scores 11 and 13. The 
Youden Index combines the sensitivity and the specificity scores to create a range from 0.00 to 
1.00. The Youden Index for the EPDS cut-off scores ranges from 0.52 to 0.63. Analysis 
demonstrates that due to the variability of sensitivity and specificity for cut-off scores there is no 
score that provides a consistently high Youden Index. 
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6 5 0.91 0.10 0.61 0.13 0.52 0.15 2.06 0.62
7 4 0.87 0.13 0.71 0.17 0.59 0.21 1.87 0.63
8 5 0.85 0.11 0.78 0.14 0.63 0.18 1.68 0.41
9 4 0.79 0.13 0.82 0.10 0.61 0.12 1.70 0.35
10 8 0.72 0.15 0.88 0.08 0.60 0.14 1.75 0.36
11 6 0.68 0.22 0.87 0.15 0.56 0.21 1.99 0.64
12 7 0.61 0.22 0.91 0.10 0.51 0.20 2.20 0.77
13 5 0.71 0.20 0.86 0.20 0.58 0.15 1.82 0.43
14 1 0.40 1.00 0.40 2.50
An optimal NND value would be close to 1.0.  For the EPDS cut-off scores the NND 
value range from 1.68 to 2.50. Consistent with Youden Index results the variability of sensitivity 
and specificity values results in no NND values that suggest an optimal cut-off score for the 
EPDS. Results in Table 5 confirm the lack of a consistent cut-off score across EPDS studies. 
Four selected studies with Youden Indices and NND values close to 1.0 have a range of cut-off 
scores from 8.5 to 12. 








Adewuya, 2005 8.5 0.94 0.97 0.91 1.099 
Agoub, 2005 10 1.00 0.88 0.88 1.136 
Agoub, 2005 11 0.96 0.95 0.91 1.099 
Agoub, 2005 12 0.92 0.96 0.88 1.136 
PPD Rate
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Table 6. Post-Partum Depression rates for Cut-Scores used for PDSS Screening Instruments
Study, Country, Year PPD Rate 
Austin, 2005, Australia 5.2%
Milgrom, 2005, Australia 8.0%
Jardi, 2006, France 16.1%
Agoub, 2005, Morocco  6.9%
Adewuya, 2005, Nigeria 14.6%
Abiodun, 2006, Nigeria 18.6%
Navarro, 2007, Spain 25.4%
Teng, 2005, Taiwan 10.3%
Pitanupong, 2007, Thailand 1.0%
Vittayanont, 2006, Thailand 1.0%
Beck, 2005, USA 18.0%
Chaudron, 2010, USA 37.0%
Flynn, 2011, USA 73.0%
Gjerdingen, 2009, USA 8.9%
Hanusa, 2006, USA 11.0%
Yawn, 2009, USA n/a 
Discussion
PPD is the number one complication during the postpartum period (Coates, Schaefer, & 
Alexander, 2004). Although in the last 50 years there has been a big advance in the prevention of 
birth complications, the prevalence of PPD is still the same. 
It is well known that half of the PPD cases are unrecognized (Georgiopoulos, Bryan, 
Wollan, & Yawn, 2001). The barriers for the screening and treatment of PPD were identified and 
it falls into two categories: 1) The patients’ barriers: which includes lack of knowledge about 
signs and symptoms or about where they can seek help, the fear of medication if they are nursing 
the baby, and the fear of looking an imperfect mother if they have depression, 2) providers’ 
barriers: Providers usually are primary care physicians, pediatricians and obstetric and 
gynecologists. Their barriers include also lack of knowledge about the best screening tools, 
signs, symptoms and treatment, in addition the restricted time and no compensation for the 
provided services (Rosenfield, 2007). 
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This study is aimed to decrease the undetectable number of PPD cases by finding the best 
practices for approaching PPD screening. It is an evidence-based study where a systematic 
review of published articles has been conducted.  
Most commonly used instrument: Results showed that 46 studies out of 82 used an 
EPDS as the PPD screening tool. EPDS is the most commonly used instruments across all 
studies and it has been translated to different languages, these findings are consistent with the 
findings of Hewitt et al. (2010). EPDS is brief, simple and takes about 5 minutes to complete. It 
is easy to administer and score, which makes it a feasible instrument to be promoted into the 
maternal and child care programs of Public Health Centers (Abiodun, 2006). Studies have also 
showed that the EPDS performs better than the traditional PPD screening instruments as the 
Beck Depression Inventory when used in postnatal period (Prichard & Harris, 1996; Ballard, 
Davis, Cullen, Moran, & Dean, 1994). EPDS have a good acceptability and is considered as a 
comfortable screening tool as the result of Gemmil, Leigh, Ericksen, and Milgrom (2006). 
Gemmil and colleagues (2006) conducted a survey to find the acceptability of the EDPS 
postpartum screening tool, 479 out of 920 of the women responded to their survey; 97% of the 
women indicated that EPDS screening was desirable, 81.2% of women rated that the screening is 
comfortable to very comfortable and only 4.3% indicated that the screening is not comfortable. 
Setting: Studies showed that 44 studies of PPD screening occurred in postnatal-prenatal 
clinics, 15 studies in maternity clinics, and 12 in community based organizations, which lead to 
the conclusion that postnatal-prenatal clinics are the best setting for performing PPD screening. 
These findings are in agreement with the Seehusen, Baldwin, Runkle, Clark, and Seehusen 
(2005) findings which showed that 70.2% of physicians always or often screened for PPD at 
postpartum gynecologic examinations, and 46% always or often screened mothers at well-child 
visits. 
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Studies were contracted worldwide, in Asia, Africa, Europe, America; Despite the 
geographic variation, overall the studies did not show s, a big change in PPD screening practices. 
The most commonly used instrument was EPDS, the administration period was around 6 weeks 
and the PPD rate had a very small variation among the different studies. It has been inferred that 
the geographic distribution is not affecting the PPD screening practices; however more studies 
have been conducted in the USA that focus on BDI, PHQ-9 and PPDS comparing to other 
countries where the focus was on EDPS. 
Administration period: According to the DSM-4 definition, PPD is the major 
depression that begins in the first four week of delivery, but according to the CDI-10 definition, 
it is the major depression that begins within six weeks of delivery.
Most of the studies had been conducted 6 weeks postnatal and they gave a PPD 
prevalence rate similar to the PPD worldwide rate of 5%-20% (Miller, 2002). However, other 
studies were started as early as the first day of delivery (Flynn, 2005) or two weeks after delivery 
(Chardon, 2007) which could explain the high rate of PPD for those studies (73% and 37% 
respectively). It has been concluded from the study that the best time for applying the PPD 
screening instrument is around 6 weeks postnatal; earlier than six weeks more false cases can be 
detected as the new mother is trying to adapt to the new baby and also due to the tiredness and 
lack of sleep the mother experiences early in the confinement period. If the screening is later 
than six weeks it will be considered as a screening for major depression, not for PPD. 
Cut-off points: Cut off score is very essential for the screening purpose. The purpose of 
this study was to find a recommended cut-off score for best PPD screening practices. At this cut­
off scores there should be a balance between the sensitivity and specificity, so the test wouldn’t 
lose its value either by having high false positive cases if the sensitivity is very high, or by 
having false negative cases if the specificity is very high. The screening tool that had been 
chosen is EDPS, the recommended cut-off score for EDPS is 10 (Cox et al., 1987). The results 
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showed inconsistency in the mean values of sensitivities and specificities as the corresponding 
cut- scores changes, and it could not find an optimal cut-off score to be recommended as the best 
value for screening. Our finding is consistent with other studies’ findings showing variability in 
the optimal cut-off scores between population studies (Buist et al., 2002; Fergerson, Jamieson, & 
Lindsay, 2002; Nishimura & Ohashi, 2010). 
Conclusion and Recommendations 
The rate of PPD and its screening practices are similar worldwide. Screening for PPD 
using EPDS as a screening tool with the recommended cut-off point in each study population, 
and having an administration period around the six weeks postnatal at perinatal clinics could be 
considered as best practices for PPD. 
There is a need for more future studies that can find the best practices for PPD within 
each country with respect to the PPD rate, the cost-effectiveness, the availability and distribution 
of perinatal clinics and the expertise in each center.  
Limitations of the Study 
This is a review study that compared different studies conducted worldwide, there are 
limitations to this study: 1. Variation in geographic location had been ignored also the cultural 
differences had not been accounted. 2. Small sample sizes of some reviewed studies. 3. 
Differences in the definition of postpartum depression between the articles. 
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Appendix 4 – List of Public Health Competencies Met 
Specific Competencies 
Domain #1: Analytic Assessment Skill 
Defines a problems 
Determines appropriate uses and limitations of both quantitative and qualitative data 
Selects and defines variables relevant to defined public health problems 
Identifies relevant and appropriate data and information sources 
Evaluates the integrity and comparability of data and identifies gaps in data sources 
Makes relevant inferences from quantitative and qualitative data 
Obtains and interprets information regarding risks and benefits to the community 
Applies data collection processes, information technology applications, and computer systems 
storage/retrieval strategies 
Recognizes how the data illuminates ethical, political, scientific, economic, and overall public 
health issues 
Domain #2: Policy Development/Program Planning Skills 
Collects, summarizes, and interprets information relevant to an issue 
Domain #3: Communication Skills 
Communicates effectively both in writing and orally, or in other ways 
Effectively presents accurate demographic, statistical, programmatic, and scientific information 
for professional and lay audiences 
Attitudes 
Listens to others in an unbiased manner, respects points of view of others, and promotes the 
expression of diverse opinions and perspectives 
Domain #4: Cultural Competency Skills 
Identifies the role of cultural, social, and behavioral factors in determining the delivery of public 
health services 
Attitudes 
Understands the dynamic forces contributing to cultural diversity 
Domain #5: Community Dimensions of Practice Skills 
Develops, implements, and evaluates a community public health assessment 
Domain #6: Basic Public Health Sciences Skills 
Defines, assesses, and understands the health status of populations, determinants of health and 
illness, factors contributing to health promotion and disease prevention, and factors influencing 
the use of health services 
Understands the historical development, structure, and interaction of public health and health 
care systems 
Identifies and applies basic research methods used in public health 
Applies the basic public health sciences including behavioral and social sciences, biostatistics, 
epidemiology, environmental public health, and prevention of chronic and infectious diseases 
and injuries 
Identifies and retrieves current relevant scientific evidence 
Identifies the limitations of research and the importance of observations and interrelationships 
Attitudes 
Develops a lifelong commitment to rigorous critical thinking 
 
             
                           
                           
     
                 
 
 
51 EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD 
Domain #8: Leadership and Systems Thinking Skills 
Helps create key values and shared vision and uses these principles to guide action 
Identifies internal and external issues that may impact delivery of essential public health services 
(i.e. strategic planning) 
Contributes to development, implementation, and monitoring of organizational performance 
standards 
